These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 33314076)

  • 1. Can the hyperthermia-mediated heat shock factor/heat shock protein 70 pathway dampen the cytokine storm during SARS-CoV-2 infection?
    Rébé C; Ghiringhelli F; Garrido C
    Br J Pharmacol; 2022 Nov; 179(21):4910-4916. PubMed ID: 33314076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of autoimmune reactivity induced by heat shock protein 70 in the pathogenesis of essential hypertension.
    Rodriguez-Iturbe B; Lanaspa MA; Johnson RJ
    Br J Pharmacol; 2019 Jun; 176(12):1829-1838. PubMed ID: 29679484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboinflammation in coronavirus disease 2019: The clot thickens.
    Iffah R; Gavins FNE
    Br J Pharmacol; 2022 May; 179(10):2100-2107. PubMed ID: 34128218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressed anti-inflammatory heat shock response in high-risk COVID-19 patients: lessons from basic research (inclusive bats), light on conceivable therapies.
    Heck TG; Ludwig MS; Frizzo MN; Rasia-Filho AA; Homem de Bittencourt PI
    Clin Sci (Lond); 2020 Aug; 134(15):1991-2017. PubMed ID: 32749472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019.
    Subramaniam S; Ruf W; Bosmann M
    Br J Pharmacol; 2022 May; 179(10):2086-2099. PubMed ID: 34235728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyroptosis targeting via mitochondria: An educated guess to innovate COVID-19 therapies.
    Singh A; Strobbe D; Campanella M
    Br J Pharmacol; 2022 May; 179(10):2081-2085. PubMed ID: 34632567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tackling COVID-19 infection through complement-targeted immunotherapy.
    Jodele S; Köhl J
    Br J Pharmacol; 2021 Jul; 178(14):2832-2848. PubMed ID: 32643798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to heat shock protein 60, 70, and 90 are not altered in the anti-SARS-CoV-2 IgG-seropositive humans without or with mild symptoms.
    Mantej J; Bednarek M; Sitko K; Świętoń M; Tukaj S
    Cell Stress Chaperones; 2021 Jul; 26(4):735-740. PubMed ID: 34080135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention.
    Kasperkiewicz M
    Cell Stress Chaperones; 2021 Jan; 26(1):1-2. PubMed ID: 33196989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to Restore Oxidative Balance That Was Disrupted by SARS-CoV-2 Infection.
    Kiełbowski K; Herian M; Pawlik A
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
    Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
    Front Immunol; 2021; 12():589095. PubMed ID: 33995341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Many Faces of JAKs and STATs Within the COVID-19 Storm.
    Grant AH; Estrada A; Ayala-Marin YM; Alvidrez-Camacho AY; Rodriguez G; Robles-Escajeda E; Cadena-Medina DA; Rodriguez AC; Kirken RA
    Front Immunol; 2021; 12():690477. PubMed ID: 34326843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
    Chong ZZ; Souayah N
    Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology.
    Song NJ; Allen C; Vilgelm AE; Riesenberg BP; Weller KP; Reynolds K; Chakravarthy KB; Kumar A; Khatiwada A; Sun Z; Ma A; Chang Y; Yusuf M; Li A; Zeng C; Evans JP; Bucci D; Gunasena M; Xu M; Liyanage NPM; Bolyard C; Velegraki M; Liu SL; Ma Q; Devenport M; Liu Y; Zheng P; Malvestutto CD; Chung D; Li Z
    J Hematol Oncol; 2022 Jan; 15(1):5. PubMed ID: 35012610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological risks and benefits of cytokine-based treatments in coronavirus disease 2019: from preclinical to clinical evidence.
    Pignataro G; Cataldi M; Taglialatela M
    Br J Pharmacol; 2022 May; 179(10):2149-2174. PubMed ID: 33512003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
    Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
    Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highlights into the pharmacology of nutraceuticals.
    Andrew R; Izzo AA
    Br J Pharmacol; 2020 Mar; 177(6):1209-1211. PubMed ID: 32133625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.